These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

106 related items for PubMed ID: 7682157

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Human prostatic cancer cells are sensitive to programmed (apoptotic) death induced by the antiangiogenic agent linomide.
    Vukanovic J, Isaacs JT.
    Cancer Res; 1995 Aug 15; 55(16):3517-20. PubMed ID: 7543015
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Potentiation of the antiangiogenic ability of linomide by androgen ablation involves down-regulation of vascular endothelial growth factor in human androgen-responsive prostatic cancers.
    Joseph IB, Isaacs JT.
    Cancer Res; 1997 Mar 15; 57(6):1054-7. PubMed ID: 9067270
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Inhibition of tumor angiogenesis and the therapeutic ability of linomide against rat prostatic cancers.
    Vukanovic J, Hartley-Asp B, Isaacs JT.
    Prostate; 1995 May 15; 26(5):235-46. PubMed ID: 7538663
    [Abstract] [Full Text] [Related]

  • 9. Inhibition of angiogenesis and metastases of the Lewis-lung cell carcinoma by the quinoline-3-carboxamide, Linomide.
    Borgström P, Torres Filho IP, Hartley-Asp B.
    Anticancer Res; 1995 May 15; 15(3):719-28. PubMed ID: 7544090
    [Abstract] [Full Text] [Related]

  • 10. Vasorelaxant effects induced by the antiangiogenic drug linomide in aortic and saphenous vein preparations of the rabbit.
    Amerini S, Filippi S, Parenti A, Ledda F, Ziche M.
    Br J Pharmacol; 1997 Dec 15; 122(8):1739-45. PubMed ID: 9422822
    [Abstract] [Full Text] [Related]

  • 11. CEP-7055: a novel, orally active pan inhibitor of vascular endothelial growth factor receptor tyrosine kinases with potent antiangiogenic activity and antitumor efficacy in preclinical models.
    Ruggeri B, Singh J, Gingrich D, Angeles T, Albom M, Yang S, Chang H, Robinson C, Hunter K, Dobrzanski P, Jones-Bolin S, Pritchard S, Aimone L, Klein-Szanto A, Herbert JM, Bono F, Schaeffer P, Casellas P, Bourie B, Pili R, Isaacs J, Ator M, Hudkins R, Vaught J, Mallamo J, Dionne C.
    Cancer Res; 2003 Sep 15; 63(18):5978-91. PubMed ID: 14522925
    [Abstract] [Full Text] [Related]

  • 12. Identification of ABR-215050 as lead second generation quinoline-3-carboxamide anti-angiogenic agent for the treatment of prostate cancer.
    Isaacs JT, Pili R, Qian DZ, Dalrymple SL, Garrison JB, Kyprianou N, Björk A, Olsson A, Leanderson T.
    Prostate; 2006 Dec 01; 66(16):1768-78. PubMed ID: 16955399
    [Abstract] [Full Text] [Related]

  • 13. Macrophage role in the anti-prostate cancer response to one class of antiangiogenic agents.
    Joseph IB, Isaacs JT.
    J Natl Cancer Inst; 1998 Nov 04; 90(21):1648-53. PubMed ID: 9811314
    [Abstract] [Full Text] [Related]

  • 14. Effect of Linomide on adhesion molecules, TNF-alpha, nitrogen oxide, and cell adhesion.
    Abdul-Hai A, Hershkoviz R, Weiss L, Lider O, Slavin S.
    Int Immunopharmacol; 2005 Feb 04; 5(2):231-9. PubMed ID: 15652754
    [Abstract] [Full Text] [Related]

  • 15. The effect of linomide on the migration and the proliferation of capillary endothelial cells elicited by vascular endothelial growth factor.
    Parenti A, Donnini S, Morbidelli L, Granger HJ, Ziche M.
    Br J Pharmacol; 1996 Oct 04; 119(4):619-21. PubMed ID: 8904633
    [Abstract] [Full Text] [Related]

  • 16. Alphavbeta3 integrin antagonist S247 decreases colon cancer metastasis and angiogenesis and improves survival in mice.
    Reinmuth N, Liu W, Ahmad SA, Fan F, Stoeltzing O, Parikh AA, Bucana CD, Gallick GE, Nickols MA, Westlin WF, Ellis LM.
    Cancer Res; 2003 May 01; 63(9):2079-87. PubMed ID: 12727823
    [Abstract] [Full Text] [Related]

  • 17. Antineoplastic effects of chemotherapeutic agents are potentiated by NM-3, an inhibitor of angiogenesis.
    Reimer CL, Agata N, Tammam JG, Bamberg M, Dickerson WM, Kamphaus GD, Rook SL, Milhollen M, Fram R, Kalluri R, Kufe D, Kharbanda S.
    Cancer Res; 2002 Feb 01; 62(3):789-95. PubMed ID: 11830534
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Linomide improves the effect of interstitial laser thermotherapy in a rat liver tumour model.
    Ivarsson K, Sturesson C, Stenram U, Tranberg KG.
    Anticancer Res; 2003 Feb 01; 23(2B):1257-63. PubMed ID: 12820380
    [Abstract] [Full Text] [Related]

  • 20. The antiangiogenic agent linomide inhibits the growth rate of von Hippel-Lindau paraganglioma xenografts to mice.
    Gross DJ, Reibstein I, Weiss L, Slavin S, Stein I, Neeman M, Abramovitch R, Benjamin LE.
    Clin Cancer Res; 1999 Nov 01; 5(11):3669-75. PubMed ID: 10589785
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.